首页 > 最新文献

Alcoholism, clinical and experimental research最新文献

英文 中文
Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System. 乙醇对中枢神经系统先天免疫反应的影响。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-11-01 DOI: 10.1111/acer.13208
J. Montesinos, S. Alfonso-Loeches, C. Guerri
The innate immune response in the central nervous system (CNS) participates in both synaptic plasticity and neural damage. Emerging evidence from human and animal studies supports the role of the neuroimmune system response in many actions of ethanol (EtOH) on the CNS. Research studies have shown that alcohol stimulates brain immune cells, microglia, and astrocytes, by activating innate immune receptors Toll-like receptors (TLRs) and NOD-like receptors (inflammasome NLRs) triggering signaling pathways, which culminate in the production of pro-inflammatory cytokines and chemokines that lead to neuroinflammation. This review focuses on evidence that indicates the participation of TLRs and the inflammasome NLRs signaling response in many effects of EtOH on the CNS, such as neuroinflammation associated with brain damage, cognitive and behavioral dysfunction, and adolescent brain development alterations. It also reviews findings that indicate the role of TLR4-dependent signaling immune molecules in alcohol consumption, reward, and addiction. The research data suggest that overactivation of TLR4 or NLRs increases pro-inflammatory cytokines and mediators to cause neural damage in the cerebral cortex and hippocampus, while modest TLR4 activation, along with the generation of certain cytokines and chemokines in specific brain areas (e.g., amygdala, ventral tegmental area), modulate neurotransmission, alcohol drinking, and alcohol rewards. Elimination of TLR4 and NLRP3 abolishes many neuroimmune effects of EtOH. Despite much progress being made in this area, there are some research gaps and unanswered questions that this review discusses. Finally, potential therapies that target neuroimmune pathways to treat neuropathological and behavioral consequences of alcohol abuse are also evaluated.
中枢神经系统(CNS)的先天免疫反应参与突触可塑性和神经损伤。来自人类和动物研究的新证据支持乙醇(EtOH)对中枢神经系统的许多作用中神经免疫系统反应的作用。研究表明,酒精刺激大脑免疫细胞、小胶质细胞和星形胶质细胞,通过激活先天免疫受体toll样受体(TLRs)和nod样受体(炎性体NLRs)触发信号通路,最终产生促炎细胞因子和趋化因子,导致神经炎症。这篇综述的重点是表明TLRs和炎性体NLRs信号反应参与了EtOH对中枢神经系统的许多影响的证据,如与脑损伤相关的神经炎症、认知和行为功能障碍以及青少年大脑发育改变。它还回顾了tlr4依赖性信号免疫分子在酒精消耗、奖励和成瘾中的作用。研究数据表明,TLR4或NLRs的过度激活增加了促炎细胞因子和介质,导致大脑皮层和海马的神经损伤,而适度的TLR4激活,以及特定脑区(如杏仁核、腹侧被皮层)某些细胞因子和趋化因子的产生,调节神经传递、饮酒和酒精奖励。消除TLR4和NLRP3可消除EtOH的许多神经免疫作用。尽管在这一领域取得了很大进展,但仍存在一些研究空白和未解决的问题,本文将对此进行讨论。最后,针对神经免疫途径治疗酒精滥用的神经病理和行为后果的潜在疗法也进行了评估。
{"title":"Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System.","authors":"J. Montesinos, S. Alfonso-Loeches, C. Guerri","doi":"10.1111/acer.13208","DOIUrl":"https://doi.org/10.1111/acer.13208","url":null,"abstract":"The innate immune response in the central nervous system (CNS) participates in both synaptic plasticity and neural damage. Emerging evidence from human and animal studies supports the role of the neuroimmune system response in many actions of ethanol (EtOH) on the CNS. Research studies have shown that alcohol stimulates brain immune cells, microglia, and astrocytes, by activating innate immune receptors Toll-like receptors (TLRs) and NOD-like receptors (inflammasome NLRs) triggering signaling pathways, which culminate in the production of pro-inflammatory cytokines and chemokines that lead to neuroinflammation. This review focuses on evidence that indicates the participation of TLRs and the inflammasome NLRs signaling response in many effects of EtOH on the CNS, such as neuroinflammation associated with brain damage, cognitive and behavioral dysfunction, and adolescent brain development alterations. It also reviews findings that indicate the role of TLR4-dependent signaling immune molecules in alcohol consumption, reward, and addiction. The research data suggest that overactivation of TLR4 or NLRs increases pro-inflammatory cytokines and mediators to cause neural damage in the cerebral cortex and hippocampus, while modest TLR4 activation, along with the generation of certain cytokines and chemokines in specific brain areas (e.g., amygdala, ventral tegmental area), modulate neurotransmission, alcohol drinking, and alcohol rewards. Elimination of TLR4 and NLRP3 abolishes many neuroimmune effects of EtOH. Despite much progress being made in this area, there are some research gaps and unanswered questions that this review discusses. Finally, potential therapies that target neuroimmune pathways to treat neuropathological and behavioral consequences of alcohol abuse are also evaluated.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"29 1","pages":"2260-2270"},"PeriodicalIF":3.2,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88458082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 146
Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18. 乙醛通过上调USP18干扰丙型肝炎病毒感染肝细胞中的干扰素α信号
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-11-01 DOI: 10.1111/acer.13226
M. Ganesan, L. Poluektova, D. Tuma, K. Kharbanda, N. Osna
BACKGROUNDAlcohol consumption exacerbates the pathogenesis of hepatitis C virus (HCV) infection and worsens disease outcomes. The exact reasons are not clear yet, but they might be partially attributed to the ability of alcohol to further suppress the innate immunity. Innate immunity is known to be already decreased by HCV in liver cells.METHODSIn this study, we aimed to explore the mechanisms of how alcohol metabolism dysregulates IFNα signaling (STAT1 phosphorylation) in HCV+ hepatoma cells. To this end, CYP2E1+ Huh7.5 cells were infected with HCV and exposed to the acetaldehyde (Ach) generating system (AGS).RESULTSContinuously produced Ach suppressed IFNα-induced STAT1 phosphorylation, but increased the level of a protease, USP18 (both measured by Western blot), which interferes with IFNα signaling. Induction of USP18 by Ach was confirmed in primary human hepatocyte cultures and in livers of ethanol-fed HCV transgenic mice. Silencing of USP18 by specific siRNA attenuated the pSTAT1 suppression by Ach. The mechanism by which Ach down-regulates pSTAT1 is related to an enhanced interaction between IFNαR2 and USP18 that finally dysregulates the cross talk between the IFN receptor on the cell surface and STAT1. Furthermore, Ach decreases ISGylation of STAT1 (protein conjugation of a small ubiquitin-like modifier, ISG15, Western blot), which preserves STAT1 activation. Suppressed ISGylation leads to an increase in STAT1 K48 polyubiquitination which allows pSTAT1 degrading by proteasome.CONCLUSIONSWe conclude that Ach disrupts IFNα-induced STAT1 phosphorylation by the up-regulation of USP18 to block the innate immunity protection in HCV-infected liver cells, thereby contributing to HCV-alcohol pathogenesis. This, in part, may explain the mechanism of HCV-infection exacerbation/progression in alcohol-abusing patients.
背景:饮酒加剧了丙型肝炎病毒(HCV)感染的发病机制,并使疾病结局恶化。确切的原因尚不清楚,但可能部分归因于酒精进一步抑制先天免疫的能力。已知先天免疫已被肝细胞中的HCV降低。方法在本研究中,我们旨在探讨酒精代谢失调HCV+肝癌细胞中IFNα信号通路(STAT1磷酸化)的机制。为此,CYP2E1+ Huh7.5细胞感染HCV并暴露于乙醛(Ach)生成系统(AGS)。结果连续产生Ach抑制IFNα诱导的STAT1磷酸化,但增加蛋白酶USP18水平(均通过Western blot检测),干扰IFNα信号传导。在原代人肝细胞培养物和乙醇喂养的HCV转基因小鼠肝脏中证实了乙酰胆碱对USP18的诱导作用。特异性siRNA沉默USP18可减弱乙酰氨基酚对pSTAT1的抑制作用。Ach下调pSTAT1的机制与IFNα r2与USP18之间的相互作用增强,最终导致细胞表面IFN受体与STAT1之间的串扰失调有关。此外,Ach降低STAT1的isg酰化(小泛素样修饰物ISG15的蛋白偶联,Western blot),从而保持STAT1的激活。抑制isg酰化导致STAT1 K48多泛素化增加,从而允许pSTAT1被蛋白酶体降解。结论Ach通过上调USP18,破坏ifn α-诱导的STAT1磷酸化,阻断hcv感染肝细胞的先天免疫保护,参与HCV-alcohol发病机制。这在一定程度上可以解释酒精滥用患者丙型肝炎病毒感染恶化/进展的机制。
{"title":"Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18.","authors":"M. Ganesan, L. Poluektova, D. Tuma, K. Kharbanda, N. Osna","doi":"10.1111/acer.13226","DOIUrl":"https://doi.org/10.1111/acer.13226","url":null,"abstract":"BACKGROUND\u0000Alcohol consumption exacerbates the pathogenesis of hepatitis C virus (HCV) infection and worsens disease outcomes. The exact reasons are not clear yet, but they might be partially attributed to the ability of alcohol to further suppress the innate immunity. Innate immunity is known to be already decreased by HCV in liver cells.\u0000\u0000\u0000METHODS\u0000In this study, we aimed to explore the mechanisms of how alcohol metabolism dysregulates IFNα signaling (STAT1 phosphorylation) in HCV+ hepatoma cells. To this end, CYP2E1+ Huh7.5 cells were infected with HCV and exposed to the acetaldehyde (Ach) generating system (AGS).\u0000\u0000\u0000RESULTS\u0000Continuously produced Ach suppressed IFNα-induced STAT1 phosphorylation, but increased the level of a protease, USP18 (both measured by Western blot), which interferes with IFNα signaling. Induction of USP18 by Ach was confirmed in primary human hepatocyte cultures and in livers of ethanol-fed HCV transgenic mice. Silencing of USP18 by specific siRNA attenuated the pSTAT1 suppression by Ach. The mechanism by which Ach down-regulates pSTAT1 is related to an enhanced interaction between IFNαR2 and USP18 that finally dysregulates the cross talk between the IFN receptor on the cell surface and STAT1. Furthermore, Ach decreases ISGylation of STAT1 (protein conjugation of a small ubiquitin-like modifier, ISG15, Western blot), which preserves STAT1 activation. Suppressed ISGylation leads to an increase in STAT1 K48 polyubiquitination which allows pSTAT1 degrading by proteasome.\u0000\u0000\u0000CONCLUSIONS\u0000We conclude that Ach disrupts IFNα-induced STAT1 phosphorylation by the up-regulation of USP18 to block the innate immunity protection in HCV-infected liver cells, thereby contributing to HCV-alcohol pathogenesis. This, in part, may explain the mechanism of HCV-infection exacerbation/progression in alcohol-abusing patients.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"17 1","pages":"2329-2338"},"PeriodicalIF":3.2,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85059240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice. 磷脂酰乙醇在研究和临床实践中的形成、消除、解释和未来的研究需求。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-11-01 DOI: 10.1111/acer.13213
J. Hahn, R. Anton, M. Javors
1 The Formation, Elimination, Interpretation and Future Research Needs of Phosphatidylethanol 2 (PEth) for Research Studies and Clinical Practice 4 Judith A. Hahn, PhD 5 University of California, San Francisco 7 Raymond F. Anton, MD 8 Medical University of South Carolina 10 Martin A. Javors, PhD 11 University of Texas Health Science Center, San Antonio 13 Address correspondence to: 14 Judith A. Hahn, PhD 15 University of California, San Francisco 16 550 16 th St. 3 rd floor 17 San Francisco, CA 94143 18 Phone: 415-476-5815 19 e-mail: judy.hahn@ucsf.edu 21 Funding: NIAAA K24AA022586 (Hahn), NIAAA U01AA020776 (Hahn), NIAAA K05AA017435 22 (Anton), R01AA022361 (Javors)
1磷脂酰乙醇的形成、消除、解释和未来研究需求2 (PEth)的研究和临床实践4 Judith A. Hahn博士5加州大学旧金山分校7 Raymond F. Anton医学博士8南卡罗来纳医科大学10 Martin A. Javors博士11德克萨斯大学圣安东尼奥分校健康科学中心13地址通信:14 Judith A. Hahn, PhD 15 California University, San Francisco 16 550 16 th St. 3 floor 17 San Francisco, CA 94143 18电话:415-476-5815 19 e-mail: judy.hahn@ucsf.edu 21资助:NIAAA K24AA022586 (Hahn), NIAAA U01AA020776 (Hahn), NIAAA K05AA017435 22 (Anton), R01AA022361 (Javors)
{"title":"The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice.","authors":"J. Hahn, R. Anton, M. Javors","doi":"10.1111/acer.13213","DOIUrl":"https://doi.org/10.1111/acer.13213","url":null,"abstract":"1 The Formation, Elimination, Interpretation and Future Research Needs of Phosphatidylethanol 2 (PEth) for Research Studies and Clinical Practice 4 Judith A. Hahn, PhD 5 University of California, San Francisco 7 Raymond F. Anton, MD 8 Medical University of South Carolina 10 Martin A. Javors, PhD 11 University of Texas Health Science Center, San Antonio 13 Address correspondence to: 14 Judith A. Hahn, PhD 15 University of California, San Francisco 16 550 16 th St. 3 rd floor 17 San Francisco, CA 94143 18 Phone: 415-476-5815 19 e-mail: judy.hahn@ucsf.edu 21 Funding: NIAAA K24AA022586 (Hahn), NIAAA U01AA020776 (Hahn), NIAAA K05AA017435 22 (Anton), R01AA022361 (Javors)","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"15 1","pages":"2292-2295"},"PeriodicalIF":3.2,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82458977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 56
Disruption of Integrated Neuronal and Astrocytic Signaling Contributes to Alcohol Use Disorder. 综合神经元和星形细胞信号的破坏有助于酒精使用障碍。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-11-01 DOI: 10.1111/acer.13227
D. Lindberg, D. Choi
Recent research into the pathophysiology of alcohol use disorder suggests that the behavioral and physical manifestations of AUD are produced by hierarchical dysfunction at the cellular, synaptic, and circuit levels. Synaptic and circuit function are highly dependent upon the activity and function of astrocytes. Therefore, dysregulation of astrocytic function may compromise synaptic activity and produce maladaptive modifications of circuit strength. In this commentary, we discuss the extensive crosstalk between neurons and astrocytes that determine synaptic strength and bioenergetic integrity, expounding upon the extensive interactions between glutamatergic neurotransmission and cellular metabolism. Furthermore, we discuss how dysregulation of astrocyte function in AUD may alter astrocyte function and compromise both excitatory neurotransmission and CNS bioenergetics.
最近对酒精使用障碍病理生理学的研究表明,AUD的行为和身体表现是由细胞、突触和回路水平的分层功能障碍产生的。突触和电路功能高度依赖于星形胶质细胞的活动和功能。因此,星形细胞功能失调可能会损害突触活动,并产生电路强度的不适应改变。在这篇评论中,我们讨论了神经元和星形胶质细胞之间广泛的串扰,这些串扰决定了突触的强度和生物能量的完整性,并阐述了谷氨酸能神经传递和细胞代谢之间广泛的相互作用。此外,我们讨论了AUD中星形胶质细胞功能失调如何改变星形胶质细胞功能并损害兴奋性神经传递和中枢神经系统生物能量学。
{"title":"Disruption of Integrated Neuronal and Astrocytic Signaling Contributes to Alcohol Use Disorder.","authors":"D. Lindberg, D. Choi","doi":"10.1111/acer.13227","DOIUrl":"https://doi.org/10.1111/acer.13227","url":null,"abstract":"Recent research into the pathophysiology of alcohol use disorder suggests that the behavioral and physical manifestations of AUD are produced by hierarchical dysfunction at the cellular, synaptic, and circuit levels. Synaptic and circuit function are highly dependent upon the activity and function of astrocytes. Therefore, dysregulation of astrocytic function may compromise synaptic activity and produce maladaptive modifications of circuit strength. In this commentary, we discuss the extensive crosstalk between neurons and astrocytes that determine synaptic strength and bioenergetic integrity, expounding upon the extensive interactions between glutamatergic neurotransmission and cellular metabolism. Furthermore, we discuss how dysregulation of astrocyte function in AUD may alter astrocyte function and compromise both excitatory neurotransmission and CNS bioenergetics.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"21 1","pages":"2309-2311"},"PeriodicalIF":3.2,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85517716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproducibility of Experiments with Laboratory Animals: What Should We Do Now? 实验动物实验的可重复性:我们现在该怎么做?
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-11-01 DOI: 10.1111/acer.13228
J. Crabbe
{"title":"Reproducibility of Experiments with Laboratory Animals: What Should We Do Now?","authors":"J. Crabbe","doi":"10.1111/acer.13228","DOIUrl":"https://doi.org/10.1111/acer.13228","url":null,"abstract":"","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"11 1","pages":"2305-2308"},"PeriodicalIF":3.2,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85192409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Withdrawal from Chronic Nicotine Exposure Produces Region-Specific Tolerance to Alcohol-Stimulated GluA1 Phosphorylation. 慢性尼古丁暴露的戒断对酒精刺激的GluA1磷酸化产生区域特异性耐受性。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-10-31 DOI: 10.1111/acer.13258
M. A. McGinn, Rod I. Paulsen, Christy A. Itoga, Muhammad A Farooq, Jonathan E Reppel, K. Edwards, Annie M. Whitaker, N. Gilpin, Scott Edwards
BACKGROUNDNicotine use increases alcohol drinking, suggesting that the combination of these drugs may produce synergistic effects in activating reward circuitry. Alternatively, use of either of these drugs may facilitate the development of cross-tolerance to the other to promote intake escalation.METHODSIn this study, adult male Wistar rats were chronically exposed to room air or chronic, intermittent nicotine vapor, which has been shown to produce symptoms of nicotine dependence as evidenced by elevated nicotine self-administration and a host of somatic and motivational withdrawal symptoms. We examined regional neuroadaptations in nicotine-experienced versus nonexperienced animals, focusing on changes in phosphorylation of the AMPA glutamate channel subunit GluA1 in reward-related brain regions as excitatory neuroadaptations are heavily implicated in both alcohol and nicotine addiction.RESULTSDuring withdrawal, nicotine exposure and alcohol challenge (1 g/kg) interactively produced neuroadaptations in GluA1 phosphorylation in a brain region-dependent manner. Alcohol robustly increased protein kinase A-mediated phosphorylation of GluA1 at serine 845 in multiple regions. However, this neuroadaptation was largely absent in 3 areas (dorsomedial prefrontal cortex, dorsal striatum, and central amygdala) in nicotine-experienced animals. This interactive effect suggests a molecular tolerance to alcohol-stimulated phosphorylation of GluA1 in the context of nicotine dependence.CONCLUSIONSNicotine may modify the rewarding or reinforcing effects of alcohol by altering glutamate signaling in a region-specific manner, thereby leading to increased drinking in heavy smokers.
背景:使用尼古丁会增加饮酒,这表明这些药物的组合可能在激活奖赏回路中产生协同效应。或者,使用这些药物中的任何一种都可能促进对另一种药物的交叉耐受性的发展,从而促进摄入量的增加。方法在本研究中,成年雄性Wistar大鼠长期暴露于室内空气或慢性间歇性尼古丁蒸气中,这已被证明会产生尼古丁依赖症状,如尼古丁自我给药量升高和一系列躯体和动机戒断症状。我们研究了有尼古丁经验的动物与没有尼古丁经验的动物的区域神经适应,重点关注奖赏相关脑区域AMPA谷氨酸通道亚基GluA1磷酸化的变化,因为兴奋性神经适应与酒精和尼古丁成瘾都有很大关系。结果在戒断期间,尼古丁暴露和酒精刺激(1 g/kg)以脑区域依赖的方式相互作用产生GluA1磷酸化的神经适应。酒精在多个区域显著增加了蛋白激酶a介导的GluA1丝氨酸845位点的磷酸化。然而,在尼古丁经历过的动物中,这种神经适应在3个区域(背内侧前额叶皮层、背侧纹状体和中央杏仁核)中基本缺失。这种相互作用表明,在尼古丁依赖的背景下,对酒精刺激的GluA1磷酸化具有分子耐受性。结论尼古丁可能通过改变特定区域的谷氨酸信号来改变酒精的奖励或强化作用,从而导致重度吸烟者饮酒增加。
{"title":"Withdrawal from Chronic Nicotine Exposure Produces Region-Specific Tolerance to Alcohol-Stimulated GluA1 Phosphorylation.","authors":"M. A. McGinn, Rod I. Paulsen, Christy A. Itoga, Muhammad A Farooq, Jonathan E Reppel, K. Edwards, Annie M. Whitaker, N. Gilpin, Scott Edwards","doi":"10.1111/acer.13258","DOIUrl":"https://doi.org/10.1111/acer.13258","url":null,"abstract":"BACKGROUND\u0000Nicotine use increases alcohol drinking, suggesting that the combination of these drugs may produce synergistic effects in activating reward circuitry. Alternatively, use of either of these drugs may facilitate the development of cross-tolerance to the other to promote intake escalation.\u0000\u0000\u0000METHODS\u0000In this study, adult male Wistar rats were chronically exposed to room air or chronic, intermittent nicotine vapor, which has been shown to produce symptoms of nicotine dependence as evidenced by elevated nicotine self-administration and a host of somatic and motivational withdrawal symptoms. We examined regional neuroadaptations in nicotine-experienced versus nonexperienced animals, focusing on changes in phosphorylation of the AMPA glutamate channel subunit GluA1 in reward-related brain regions as excitatory neuroadaptations are heavily implicated in both alcohol and nicotine addiction.\u0000\u0000\u0000RESULTS\u0000During withdrawal, nicotine exposure and alcohol challenge (1 g/kg) interactively produced neuroadaptations in GluA1 phosphorylation in a brain region-dependent manner. Alcohol robustly increased protein kinase A-mediated phosphorylation of GluA1 at serine 845 in multiple regions. However, this neuroadaptation was largely absent in 3 areas (dorsomedial prefrontal cortex, dorsal striatum, and central amygdala) in nicotine-experienced animals. This interactive effect suggests a molecular tolerance to alcohol-stimulated phosphorylation of GluA1 in the context of nicotine dependence.\u0000\u0000\u0000CONCLUSIONS\u0000Nicotine may modify the rewarding or reinforcing effects of alcohol by altering glutamate signaling in a region-specific manner, thereby leading to increased drinking in heavy smokers.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"1 1","pages":"2537-2547"},"PeriodicalIF":3.2,"publicationDate":"2016-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84841440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge and Shp Deficiency. 代谢组学分析显示,慢性酒精+暴食和Shp缺乏改变了代谢物的明显循环变化。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-10-28 DOI: 10.1111/acer.13257
Melanie Tran, Zhihong Yang, S. Liangpunsakul, Li Wang
BACKGROUNDChronic ethanol (EtOH) consumption causes alcoholic liver disease (ALD), and disruption of the circadian system facilitates the development of ALD. Small heterodimer partner (SHP) is a nuclear receptor and critical regulator of hepatic lipid metabolism. This study aimed at depicting circadian metabolomes altered by chronic EtOH-plus-binge and Shp deficiency using high-throughput metabolomics.METHODSWild-type (WT) C57BL/6 and Shp-/- mice were fed the control diet (CD) or Lieber-DeCarli EtOH liquid diet (ED) for 10 days followed by a single bout of maltose (CD + M) or EtOH (ED + E) binge on the 11th day. Serum and liver were collected over a 24-hour light/dark (LD) cycle at Zeitgeber time ZT12, ZT18, ZT0, and ZT6, and metabolomics was performed using gas chromatography-mass spectrometry.RESULTSA total of 110 metabolites were identified in liver and of those 80 were also present in serum from pathways of carbohydrates, lipids, pentose phosphate, amino acids, nucleotides, and tricarboxylic acid cycle. In the liver, 91% of metabolites displayed rhythmicity with ED + E, whereas in the serum, only 87% were rhythmic. Bioinformatics analysis identified unique metabolome patterns altered in WT CD + M, WT ED + E, Shp-/- CD + M, and Shp-/- ED + E groups. Specifically, metabolites from the nucleotide and amino acid pathway (ribose, glucose-6-phosphate, glutamic acid, aspartic acid, and sedoheptulose-7-P) were elevated in Shp-/- CD + M mice during the dark cycle, whereas metabolites including N-methylalanine, 2-hydroxybutyric acid, and 2-hydroxyglutarate were elevated in WT ED + E mice during the light cycle. The rhythmicity and abundance of other individual metabolites were also significantly altered by both control and EtOH diets.CONCLUSIONSMetabolomics provides a useful means to identify unique metabolites altered by chronic EtOH-plus-binge.
背景:慢性乙醇(EtOH)消耗导致酒精性肝病(ALD),昼夜节律系统的破坏促进了ALD的发展。小异二聚体(SHP)是一种核受体,是肝脏脂质代谢的重要调节因子。本研究旨在利用高通量代谢组学描述慢性etoh +暴食和Shp缺乏所改变的昼夜节律代谢组学。方法野生型(WT) C57BL/6和Shp-/-小鼠分别饲喂对照饲粮(CD)或lieberman - decarli EtOH液体饲粮(ED) 10 d,第11天饲喂麦芽糖(CD + M)或EtOH (ED + E)单次暴食。在Zeitgeber时间ZT12、ZT18、ZT0和ZT6的24小时光/暗(LD)周期内收集血清和肝脏,并采用气相色谱-质谱法进行代谢组学分析。结果在肝脏中鉴定出110种sa代谢物,其中80种代谢物也存在于血清碳水化合物、脂质、戊糖磷酸、氨基酸、核苷酸和三羧酸循环途径中。在肝脏中,91%的代谢物表现出ED + E节律性,而在血清中,只有87%的代谢物表现出节律性。生物信息学分析确定了WT CD + M、WT ED + E、Shp-/- CD + M和Shp-/- ED + E组中独特的代谢组模式。具体来说,Shp-/- CD + M小鼠的核苷酸和氨基酸途径的代谢物(核糖、葡萄糖-6-磷酸、谷氨酸、天冬氨酸和sedoheptulose-7-P)在黑暗周期中升高,而WT ED + E小鼠的代谢物包括n -甲基丙氨酸、2-羟基丁酸和2-羟基戊二酸在光照周期中升高。其他个体代谢物的节律性和丰度也被对照组和EtOH饮食显著改变。结论代谢组学提供了一种有效的方法来鉴定慢性etoh +暴食所改变的独特代谢物。
{"title":"Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge and Shp Deficiency.","authors":"Melanie Tran, Zhihong Yang, S. Liangpunsakul, Li Wang","doi":"10.1111/acer.13257","DOIUrl":"https://doi.org/10.1111/acer.13257","url":null,"abstract":"BACKGROUND\u0000Chronic ethanol (EtOH) consumption causes alcoholic liver disease (ALD), and disruption of the circadian system facilitates the development of ALD. Small heterodimer partner (SHP) is a nuclear receptor and critical regulator of hepatic lipid metabolism. This study aimed at depicting circadian metabolomes altered by chronic EtOH-plus-binge and Shp deficiency using high-throughput metabolomics.\u0000\u0000\u0000METHODS\u0000Wild-type (WT) C57BL/6 and Shp-/- mice were fed the control diet (CD) or Lieber-DeCarli EtOH liquid diet (ED) for 10 days followed by a single bout of maltose (CD + M) or EtOH (ED + E) binge on the 11th day. Serum and liver were collected over a 24-hour light/dark (LD) cycle at Zeitgeber time ZT12, ZT18, ZT0, and ZT6, and metabolomics was performed using gas chromatography-mass spectrometry.\u0000\u0000\u0000RESULTS\u0000A total of 110 metabolites were identified in liver and of those 80 were also present in serum from pathways of carbohydrates, lipids, pentose phosphate, amino acids, nucleotides, and tricarboxylic acid cycle. In the liver, 91% of metabolites displayed rhythmicity with ED + E, whereas in the serum, only 87% were rhythmic. Bioinformatics analysis identified unique metabolome patterns altered in WT CD + M, WT ED + E, Shp-/- CD + M, and Shp-/- ED + E groups. Specifically, metabolites from the nucleotide and amino acid pathway (ribose, glucose-6-phosphate, glutamic acid, aspartic acid, and sedoheptulose-7-P) were elevated in Shp-/- CD + M mice during the dark cycle, whereas metabolites including N-methylalanine, 2-hydroxybutyric acid, and 2-hydroxyglutarate were elevated in WT ED + E mice during the light cycle. The rhythmicity and abundance of other individual metabolites were also significantly altered by both control and EtOH diets.\u0000\u0000\u0000CONCLUSIONS\u0000Metabolomics provides a useful means to identify unique metabolites altered by chronic EtOH-plus-binge.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"39 1","pages":"2548-2556"},"PeriodicalIF":3.2,"publicationDate":"2016-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87091043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice. 免疫球蛋白A基因缺失不影响小鼠酒精性脂肪性肝炎的发生。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-10-14 DOI: 10.1111/acer.13239
Tatsuo Inamine, An-Ming Yang, Lirui Wang, Kuei-Chuan Lee, C. Llorente, B. Schnabl
BACKGROUNDChronic alcohol abuse is associated with intestinal dysbiosis and bacterial translocation. Translocated commensal bacteria contribute to alcoholic liver disease. Secretory immunoglobulin A (IgA) in the intestine binds bacteria and prevents bacterial translocation.METHODSTo investigate the functional role of IgA in ethanol (EtOH)-induced liver disease in mice, we subjected wild type (WT) and IgA-deficient littermate mice to Lieber-DeCarli models of chronic EtOH administration and the model of chronic and binge EtOH feeding (the NIAAA model).RESULTSChronic EtOH feeding increased systemic levels of IgA, while fecal IgA was reduced in C57BL/6 WT mice. WT and Iga-/- littermate mice showed similar liver injury, steatosis, and inflammation following 4 weeks of EtOH feeding or chronic and binge EtOH feeding. IgA deficiency did not affect intestinal absorption or hepatic metabolism of EtOH. Pretreatment with ampicillin elevated intestinal IgA in WT littermate mice. Despite increased intestinal IgA, WT littermate mice exhibited a similar degree of liver disease compared with Iga-/- mice after 7 weeks of EtOH feeding. Interestingly, bacterial translocation to mesenteric lymph nodes was increased in Iga-/- mice fed an isocaloric diet, but was the same after EtOH feeding relative to WT littermate mice. The absence of intestinal IgA was associated with increased intestinal and plasma IgM in Iga-/- mice after EtOH feeding.CONCLUSIONSOur findings indicate that absence of IgA does not affect the development of alcoholic liver disease in mice. Loss of intestinal IgA is compensated by increased levels of intestinal IgM, which likely limits bacterial translocation after chronic EtOH administration.
背景:慢性酒精滥用与肠道生态失调和细菌易位有关。易位的共生菌可导致酒精性肝病。分泌免疫球蛋白A (IgA)在肠道结合细菌和防止细菌易位。方法为了研究IgA在乙醇(EtOH)诱导的小鼠肝脏疾病中的功能作用,我们采用Lieber-DeCarli模型和NIAAA模型分别对野生型(WT)和IgA缺乏的小鼠进行慢性EtOH给药和慢性暴食EtOH模型。结果C57BL/6 WT小鼠慢性EtOH喂养增加了全身IgA水平,降低了粪便IgA水平。WT和Iga-/-同窝小鼠在4周的乙基羟基乙酸喂养或慢性和暴食乙基羟基乙酸喂养后,表现出类似的肝损伤、脂肪变性和炎症。IgA缺乏不影响EtOH的肠道吸收和肝脏代谢。氨苄西林预处理可提高WT仔鼠肠道IgA水平。尽管肠道IgA增加,但在7周的EtOH喂养后,WT幼崽小鼠表现出与IgA -/-小鼠相似程度的肝脏疾病。有趣的是,喂食等热量饮食的Iga-/-小鼠中,细菌向肠系膜淋巴结的易位增加,但喂食EtOH后,细菌向肠系膜淋巴结的易位与WT幼崽小鼠相同。EtOH饲喂IgA -/-小鼠后,肠道IgA缺失与肠道和血浆IgM升高有关。结论IgA的缺失不影响小鼠酒精性肝病的发生。肠道IgM水平的增加弥补了肠道IgA的损失,这可能限制了慢性EtOH给药后的细菌易位。
{"title":"Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice.","authors":"Tatsuo Inamine, An-Ming Yang, Lirui Wang, Kuei-Chuan Lee, C. Llorente, B. Schnabl","doi":"10.1111/acer.13239","DOIUrl":"https://doi.org/10.1111/acer.13239","url":null,"abstract":"BACKGROUND\u0000Chronic alcohol abuse is associated with intestinal dysbiosis and bacterial translocation. Translocated commensal bacteria contribute to alcoholic liver disease. Secretory immunoglobulin A (IgA) in the intestine binds bacteria and prevents bacterial translocation.\u0000\u0000\u0000METHODS\u0000To investigate the functional role of IgA in ethanol (EtOH)-induced liver disease in mice, we subjected wild type (WT) and IgA-deficient littermate mice to Lieber-DeCarli models of chronic EtOH administration and the model of chronic and binge EtOH feeding (the NIAAA model).\u0000\u0000\u0000RESULTS\u0000Chronic EtOH feeding increased systemic levels of IgA, while fecal IgA was reduced in C57BL/6 WT mice. WT and Iga-/- littermate mice showed similar liver injury, steatosis, and inflammation following 4 weeks of EtOH feeding or chronic and binge EtOH feeding. IgA deficiency did not affect intestinal absorption or hepatic metabolism of EtOH. Pretreatment with ampicillin elevated intestinal IgA in WT littermate mice. Despite increased intestinal IgA, WT littermate mice exhibited a similar degree of liver disease compared with Iga-/- mice after 7 weeks of EtOH feeding. Interestingly, bacterial translocation to mesenteric lymph nodes was increased in Iga-/- mice fed an isocaloric diet, but was the same after EtOH feeding relative to WT littermate mice. The absence of intestinal IgA was associated with increased intestinal and plasma IgM in Iga-/- mice after EtOH feeding.\u0000\u0000\u0000CONCLUSIONS\u0000Our findings indicate that absence of IgA does not affect the development of alcoholic liver disease in mice. Loss of intestinal IgA is compensated by increased levels of intestinal IgM, which likely limits bacterial translocation after chronic EtOH administration.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"55 1","pages":"2604-2613"},"PeriodicalIF":3.2,"publicationDate":"2016-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76413495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development. 痛觉肽受体作为治疗酒精使用障碍的靶点:推进药物开发的挑战
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-10-01 DOI: 10.1111/acer.13222
R. Litten
{"title":"Nociceptin Receptor as a Target to Treat Alcohol Use Disorder: Challenges in Advancing Medications Development.","authors":"R. Litten","doi":"10.1111/acer.13222","DOIUrl":"https://doi.org/10.1111/acer.13222","url":null,"abstract":"","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"34 1","pages":"2299-2304"},"PeriodicalIF":3.2,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74053315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Alcohol Withdrawal Increases Protein Kinase A Activity in the Rat Inferior Colliculus. 戒酒增加大鼠下丘蛋白激酶A活性。
IF 3.2 3区 医学 Q1 Medicine Pub Date : 2016-09-26 DOI: 10.1111/acer.13223
Luli R. Akinfiresoye, Clive Miranda, D. Lovinger, P. N'Gouemo
BACKGROUNDCyclic AMP-dependent protein kinase A (PKA) signaling is a key target for the action of alcohol and may therefore play a role in the pathophysiology of alcohol withdrawal seizures (AWSs). Here, we investigated the role of PKA activity with respect to increased seizure susceptibility in rats that were subjected to alcohol withdrawal.METHODSAdult male Sprague Dawley rats received 3 daily doses of ethanol (EtOH) (or vehicle) for 4 consecutive days. Rats were then tested for susceptibility to acoustically evoked AWSs 3, 24, and 48 hours after the last alcohol dose. In separate experiments, the inferior colliculus (IC) was collected at these same time points from rats subjected to alcohol withdrawal and control rats following alcohol withdrawal. PKA activity, catalytic Cα (PKACα ) protein, regulatory RIIα (PKARIIα ) protein, and RIIβ (PKARIIβ ) protein were measured in the IC. Lastly, in situ pharmacological studies were performed to evaluate whether inhibiting PKA activity in the IC suppressed AWSs.RESULTSIn the EtOH-treated group, AWSs were observed at the 24-hour time point, but not at the 3-hour or 48-hour time points. In the IC, PKA activity was significantly higher both 3 hours (i.e., before AWS susceptibility) and 24 hours after the last alcohol dose (when AWS susceptibility peaked) than in control rats. Consistent with these findings, protein levels of the PKACα subunit were significantly increased in the IC both 3 and 24 hours after the last alcohol dose. Lastly, in situ inhibition of PKA activity within the IC suppressed AWSs.CONCLUSIONSThe increase in PKA activity and PKACα protein expression in the IC preceded the occurrence of AWSs, and inhibiting PKA activity within the IC suppressed acoustically evoked AWSs. Together, these findings suggest that altered PKA activity plays a key role in the pathogenesis of AWSs.
背景环amp依赖性蛋白激酶A (PKA)信号是酒精作用的关键靶点,因此可能在酒精戒断性发作(AWSs)的病理生理中发挥作用。在这里,我们研究了PKA活性在戒酒大鼠癫痫易感性增加中的作用。方法成年雄性sd大鼠连续4 d,每天3次灌胃乙醇(EtOH)。然后在最后一次酒精剂量后3、24和48小时测试大鼠对声诱发AWSs的敏感性。在不同的实验中,在相同的时间点采集酒精戒断大鼠和酒精戒断后的对照大鼠的下丘(IC)。在IC中测定PKA活性、催化Cα (PKACα)蛋白、调控性RIIα (PKARIIα)蛋白和RIIβ (PKARIIβ)蛋白。最后,通过原位药理学研究来评价抑制IC中PKA活性是否能抑制AWSs。结果etoh治疗组在24小时时间点观察到aws,而在3小时和48小时时间点没有观察到aws。在IC中,PKA活性在最后一次酒精剂量后3小时(即AWS易感前)和24小时(即AWS易感高峰时)均显著高于对照大鼠。与这些发现一致,在最后一次酒精剂量后3和24小时,IC中PKACα亚基的蛋白水平显著升高。最后,IC中PKA活性的原位抑制抑制了AWSs。结论IC中PKA活性和PKACα蛋白表达的增加先于AWSs的发生,抑制IC内PKA活性可抑制声诱发的AWSs。总之,这些发现表明PKA活性的改变在AWSs的发病机制中起着关键作用。
{"title":"Alcohol Withdrawal Increases Protein Kinase A Activity in the Rat Inferior Colliculus.","authors":"Luli R. Akinfiresoye, Clive Miranda, D. Lovinger, P. N'Gouemo","doi":"10.1111/acer.13223","DOIUrl":"https://doi.org/10.1111/acer.13223","url":null,"abstract":"BACKGROUND\u0000Cyclic AMP-dependent protein kinase A (PKA) signaling is a key target for the action of alcohol and may therefore play a role in the pathophysiology of alcohol withdrawal seizures (AWSs). Here, we investigated the role of PKA activity with respect to increased seizure susceptibility in rats that were subjected to alcohol withdrawal.\u0000\u0000\u0000METHODS\u0000Adult male Sprague Dawley rats received 3 daily doses of ethanol (EtOH) (or vehicle) for 4 consecutive days. Rats were then tested for susceptibility to acoustically evoked AWSs 3, 24, and 48 hours after the last alcohol dose. In separate experiments, the inferior colliculus (IC) was collected at these same time points from rats subjected to alcohol withdrawal and control rats following alcohol withdrawal. PKA activity, catalytic Cα (PKACα ) protein, regulatory RIIα (PKARIIα ) protein, and RIIβ (PKARIIβ ) protein were measured in the IC. Lastly, in situ pharmacological studies were performed to evaluate whether inhibiting PKA activity in the IC suppressed AWSs.\u0000\u0000\u0000RESULTS\u0000In the EtOH-treated group, AWSs were observed at the 24-hour time point, but not at the 3-hour or 48-hour time points. In the IC, PKA activity was significantly higher both 3 hours (i.e., before AWS susceptibility) and 24 hours after the last alcohol dose (when AWS susceptibility peaked) than in control rats. Consistent with these findings, protein levels of the PKACα subunit were significantly increased in the IC both 3 and 24 hours after the last alcohol dose. Lastly, in situ inhibition of PKA activity within the IC suppressed AWSs.\u0000\u0000\u0000CONCLUSIONS\u0000The increase in PKA activity and PKACα protein expression in the IC preceded the occurrence of AWSs, and inhibiting PKA activity within the IC suppressed acoustically evoked AWSs. Together, these findings suggest that altered PKA activity plays a key role in the pathogenesis of AWSs.","PeriodicalId":7410,"journal":{"name":"Alcoholism, clinical and experimental research","volume":"8 1","pages":"2359-2367"},"PeriodicalIF":3.2,"publicationDate":"2016-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83495761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
Alcoholism, clinical and experimental research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1